Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Grant or award Chief Operating Officer acquired 45,800 shares (grant or award)
  2. 4 Grant or award President acquired 45,800 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 105,700 shares (grant or award)
  4. 4 Open-market sale Chief Financial Officer sold 2,453 shares at an average $30.75 ($75,430)
  5. 4 Open-market sale General Counsel sold 2,523 shares at an average $30.75 ($77,582)
  6. 4 Open-market sale Chief Operating Officer sold 16,482 shares at an average $30.75 ($506,822)
  7. 4 Open-market sale President sold 4,436 shares at an average $30.75 ($136,407)
  8. 4 Open-market sale Chief Executive Officer sold 13,043 shares at an average $30.75 ($401,073)
  9. 4 Open-market sale Chief Operating Officer sold 12,677 shares at $26.28 ($333,152)
  10. 4 Grant or award Chief Medical Officer acquired 42,500 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale General Counsel sold 2,922 shares at an average $21.45 ($62,673)
  13. 4 Open-market sale Chief Executive Officer sold 8,854 shares at an average $21.45 ($189,908)
  14. 4 Open-market sale Chief Operating Officer sold 12,695 shares at an average $21.45 ($272,293)
  15. 4 Open-market sale President sold 4,870 shares at an average $21.45 ($104,456)
  16. 4 Grant or award Director acquired 4,100 shares (grant or award)
  17. 4 Grant or award Director acquired 4,100 shares (grant or award)
  18. 4 Grant or award Director acquired 4,100 shares (grant or award)
  19. 4 Grant or award Director acquired 4,100 shares (grant or award)
  20. 4 Grant or award Director acquired 4,100 shares (grant or award)

Page 8 of 15 · 290 filings